| DC Field | Value | Language |
|---|
| dc.contributor.author | Abdullah Mohammed Al-Dhuraibi | - |
| dc.contributor.author | Ahmad Khalaf Alkhawaldeh | - |
| dc.contributor.author | Wadah Mohammed Al-Dhuraibi | - |
| dc.contributor.author | Peresypkina, A. A. | - |
| dc.date.accessioned | 2023-10-03T09:03:39Z | - |
| dc.date.available | 2023-10-03T09:03:39Z | - |
| dc.date.issued | 2023 | - |
| dc.identifier.citation | Evaluation of safety, efficacy and pharmacokinetics of Eltrombopag in patients with chronic immune thrombocytopenia: Meta-analysis of randomized controlled trials / Abdullah Mohammed Al-Dhuraibi [et al.] // Research Results in Pharmacology. - 2023. - Vol.9, №2.-P. 105-113. | ru |
| dc.identifier.uri | http://dspace.bsu.edu.ru/handle/123456789/56821 | - |
| dc.description.abstract | The present meta-analysis is to evaluate the safety and efficiency of Eltrombopag in the prevention and therapy of Immune thrombocytopenia | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | Eltrombopag | ru |
| dc.subject | immune thrombocytopenia | ru |
| dc.subject | safety | ru |
| dc.subject | efficacy | ru |
| dc.subject | thrombopoietin agonists | ru |
| dc.subject | meta-analysis | ru |
| dc.title | Evaluation of safety, efficacy and pharmacokinetics of Eltrombopag in patients with chronic immune thrombocytopenia: Meta-analysis of randomized controlled trials | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 9, № 2
|
